Palleon Pharmaceuticals Inc.
https://palleonpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Palleon Pharmaceuticals Inc.
Henlius Pursues Two-Pronged Approach In Quest For Novel ADCs
Moving decisively but not hurriedly, Henlius is taking a two-pronged approach to join the global ADC race. The first two molecules developed via its in-licensed novel linker-payload platform have entered the clinical stage, while its own proprietary programs are seeing steady R&D progress, the Chinese firm's head of early R&D tells Scrip in an interview.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice